PortViewPortView
Certara logo

Certara (CERT) Stock Analysis

NASDAQHealthcareMedical - Healthcare Information Services

$8.23+1.54%
1-year price historyRange $4.48 – $13.60
52-week range$8.23
$4.45$13.88

What Certara does

Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative biosimulation software and expertise. Its extensive portfolio of technology-enabled services includes mechanistic and empirical biosimulation, strategic guidance for drug development and regulatory affairs, clinical pharmacology, model-based meta-analysis, specialized regulatory writing and medical communications, regulatory operations support, and market access consultation. Furthermore, Certara offers a robust suite of software platforms covering mechanistic and empirical PK/PD biosimulation, data standardization and compliance, scientific informatics, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions, and market access communication. The company's clientele primarily comprises biopharmaceutical firms, academic institutions, and governmental organizations. Established in 2008 and headquartered in Princeton, New Jersey, Certara maintains a significant global presence, with operations spanning numerous countries including the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China.

Key metrics

Market cap
$1.28B
P/E (TTM)
20.56
EPS (TTM)
$0.40
Beta
1.41
Dividend yield
0.00%
Revenue / share
$2.65
50-day avg
$7.45
200-day avg
$7.22
52-week high
$13.88
52-week low
$4.45
CEO
Jon Resnick

ETFs linked to CERT

Broad-market and Healthcare sector ETFs an investor holding Certara is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CERT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CERT in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Certara?
Certara trades under the ticker CERT on NASDAQ.
Which exchange is CERT listed on?
CERT is listed on NASDAQ.
What sector does Certara operate in?
Certara is classified in the Healthcare sector (Medical - Healthcare Information Services industry).
How can PortView help analyze CERT in a portfolio?
PortView shows CERT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.